Rising Incidence Of Sports-Related Injuries Due To Increasing Participation In High-Intensity Sports And Recreational Activities Is Supporting Development Across The Non-Opioid Pain Treatment Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Non-Opioid Pain Treatment Market During 2026–2030?

The non-opioid pain treatment market size has demonstrated significant expansion in recent years. Forecasts indicate a rise from $55.31 billion in 2025 to $60.32 billion by 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. Historically, this expansion has been driven by factors such as the increasing prevalence of chronic pain conditions, heightened awareness regarding opioid-related risks, the limited availability of non-opioid alternatives, an increase in orthopedic and musculoskeletal procedures, and the expansion of hospital and clinic infrastructure dedicated to pain management.

The non-opioid pain treatment market is set to experience significant expansion in the upcoming years. Its valuation is expected to climb to $84.36 billion by 2030, achieving an 8.7% compound annual growth rate (CAGR). This projected growth throughout the forecast period can be attributed to several factors, including the advancement of innovative non-opioid therapeutics, the broader implementation of digital health monitoring and telemedicine solutions for pain, the increasing adoption of combination therapies, heightened government initiatives aimed at pain management, and a surge in investment towards personalized pain care and alternative treatments. Key trends anticipated during this period encompass a rise in the uptake of non-opioid pain management approaches, expanded utilization of medical cannabis and omega-3 fatty acid supplements, an increase in topical and injectable pain relief products, the broadening of pain management services across hospitals and clinics, and the integration of non-pharmacological therapies suchs as acupuncture and TENS.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp

Which Growth Drivers Are Expected To Support The Non-Opioid Pain Treatment Market Forward?

The increasing occurrence of sports-related injuries is projected to stimulate the expansion of the non-opioid pain treatment market moving forward. These injuries are physical traumas that arise during sports or exercise activities. The escalating frequency of sports-related injuries is attributed to a rise in participation in high-intensity sports and recreational pursuits, which heightens the risk of physical trauma for athletes. Non-opioid pain treatment is advantageous for sports-related injuries by delivering effective pain relief and inflammation reduction without the hazards associated with opioid consumption, thereby promoting quicker recovery, better function, and safer long-term management. For instance, in October 2024, according to the Howden Group Holdings Ltd, a UK-based insurance intermediary company, in the 2023-24 football season, Europe’s top five leagues recorded 4,123 injuries, marking a 4% increase compared to the previous season. Thus, the escalating incidence of sports-related injuries is fueling the growth of the non-opioid pain treatment market.

What Segment Types Are Included In The Non-Opioid Pain Treatment Market Analysis?

The non-opioid pain treatment market covered in this report is segmented –

1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products

2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes

3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies

5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications

Subsegments:

1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products

2) By Menthol Containing: Topical Creams, Gels, Sprays

3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements

4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A

5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays

6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices

Which Trends Are Contributing To Changes In The Non-Opioid Pain Treatment Market?

Major companies operating in the non-opioid pain treatment market are prioritizing innovations in drug formulations, such as non-opioid oral treatment, to deliver effective pain relief and minimize the dangers associated with opioid use and addiction. Non-opioid oral treatment refers to pain-relieving drugs administered orally that do not include opioids and function through alternative mechanisms, such as reducing inflammation, modulating nerve signals, or acting on specific receptors, to manage pain without the addiction potential or respiratory depression often linked to opioids. For instance, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, introduced JOURNAVX, a first-in-class non-opioid therapy that provides effective relief for moderate-to-severe acute pain. This cutting-edge non-opioid treatment employs targeted modulation of pain pathways, offers a favorable safety profile, and delivers a rapid onset of action, enabling strong pain control, reduced dependency potential, and enhanced patient well-being. It ensures focused pain management, lowers addiction risks, and supports faster recovery and better quality of life for patients experiencing acute pain.

Which Organizations Are Involved In The Non-Opioid Pain Treatment Market?

Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA

Access The Complete Non-Opioid Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report

Which Area Represents The Largest Portion Of The Non-Opioid Pain Treatment Market?

North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Non-Opioid Pain Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp

Browse Through More Reports Similar to the Global Non-Opioid Pain Treatment Market 2026, By The Business Research Company

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyolefin Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyolefin-pipes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795